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Abstract
Background: Nurses make  a  valuable  contribution  to  pain  services  and  have  the  potential  to
improve the safety and effectiveness of pain management.  A  recent  addition  to  the  role  of  the
specialist pain nurse  in  the  United  Kingdom  has  been  the  introduction  of  prescribing  rights,
however there is a lack of literature about their role in prescribing pain medication.
Objective: The aim of this study was to develop a profile of the  experience,  role  and  prescribing
practice of these nurses.
Design: A descriptive questionnaire survey
Setting:  192 National Health Service public  hospital  inpatient  pain  services  across  the  United
Kingdom
Participants: 161 qualified  nurse  prescribers  were  invited  to  participate,  representing  98%  of
known nurse prescribers contributing to inpatient  pain  services.   The  survey  was  completed  in
November 2009 by 137 nurses; a response rate of 85%.
Results: Compared with nurse prescribers in the  United  Kingdom  in  general,  participants  were
highly qualified and experienced pain specialists. Fifty-six percent had qualified as a prescriber  in
the past 3 years and 22% reported that plans were underway for more nurses to undertake  a  nurse
prescribing qualification. Although all participants worked  in  inpatient  pain  services,  35%  also
covered chronic pain (outpatient) services and 90% treated more than one  pain  type.  A  range  of
pain medications were prescribed, averaging 19.5 items  per  week.  The  role  contained  a  strong
educational component and contributed to informing organisational policy  on  pain  management.
Prescribing was said to improve nurses’ ability to  promote  evidence-based  practice  but  benefits
were limited by legislation on prescribing controlled drugs.
Conclusions: Findings demonstrate that pain nurses are increasingly adopting  prescribing  as  part
of their advanced nurse role. This has implications for the development needs of pain nurses in the
United Kingdom and the future role development of nurses in other countries.
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What is already known about the topic?
• Nurses play a key role in hospital inpatient pain services within the UK
• Pain is an area for which qualified nurse prescribers are known to prescribe medication
• Specialist pain nurses are known to be involved in providing education about pain
management and medication but little is known about their role in prescribing pain
medication.
What this paper adds?
• The majority of nurses who prescribe for inpatient pain are highly qualified and
experienced pain specialists with 56.9% qualified to masters or PhD level
• Nurses are prescribing a range of medications for patients in pain, although prescription of
controlled drugs is curtailed by legislative control which is reported to hamper good
practice
• Nurse prescribing has expanded in this area since 2006 with 56% having qualified as a
nurse prescriber within the past 3 years.
1. Introduction
Effective acute pain  management  is  necessary  not  only  for  humanitarian  reasons  but  also  to
promote recovery, prevent complications, reduce the  risk  of  chronic  pain  and  improve  service
efficiency (The Royal College of Anaesthetists, 2009). Dedicated Acute Pain Services (APS) have
been  developed  in  the  USA,  Canada,  New  Zealand  and  across  Europe   (Nagi,   2004).   The
development of APS in the United Kingdom (UK) began in  the  1990’s  following  an  influential
report by the Royal College of Surgeons and the College of Anaesthetists (1990), which identified
low   standards   of   care   for   postoperative   pain   and   recommended    the    development    of
multidisciplinary teams to assume responsibility for  pain  management,  staff  training,  audit  and
research. Since then, the number of APS has steadily  increased  (McDonnell  et  al.,  2003,  Nagi,
2004, Powell et al., 2004). While the remit of these pain services  was  initially  to  improve  acute
post-operative pain, in some areas this has  expanded  to  include  the  management  of  other  pain
types such as cancer pain and chronic pain (Powell et al., 2004, Counsell, 2008).
The input of nurse specialists in the provision of APS has been advocated  as  good  practice  (The
Royal College of Anaesthetists and The Pain Society, 2003). In the UK, around 80% of APS  have
nurse involvement and nurses provide the largest time commitment out of all  professional  groups
involved (Clinical Standards Advisory Group, 2000). The role that nurses play within  pain  teams
is continually evolving. A survey of pain nurse specialist members of the British  Pain  Society  in
the UK indicated that some nurses now manage all inpatient pain  rather  than  just  post-operative
pain (Williamson-Swift, 2007).
Nurse prescribing was introduced in the UK in order to improve patient care and make  better  use
of the  skills  of  healthcare  professionals  (Department  of  Health  (DH)  2006).   As  of  2003  in
England, Northern Ireland and Scotland (and 2007 in Wales), nurses have been able  to  undertake
a  dual  qualification  as  a  Nurse  Independent  Prescriber  (NIP)  and   a   Nurse   Supplementary
Prescriber (NSP). These  are  two  different  methods  of  prescribing.  Through  NIP,  nurses  may
independently prescribe any medicine, including a limited number of Controlled  Drugs,  provided
that medicines are within  the  prescriber’s  area  of  competence  (DH,  2005).  By  contrast,  NSP
occurs in collaboration with the patient’s doctor;  the  patient  is  diagnosed  by  the  doctor  and  a
treatment plan formulated using a document called a Clinical Management Plan (CMP). The CMP
sets out the parameters within which the nurse can vary the patient’s prescriptions and can include
any drug, controlled or otherwise (DH, 2005). Whereas nurses can prescribe any Controlled  Drug
through  NSP,  current  legislation  described  by  the  Home   Office   (2007)   determines   which
controlled  drugs  can  be  prescribed  via  NIP  according  to  indication  or  treatment   (e.g.   post
operative  pain  relief,  palliative  care)  and  route  of  administration.  This  legislation  has   been
reviewed and a recommendation made to lift these restrictions (Home Office, 2007).
To be accepted to train as a NIP/NSP, nurses must have the necessary  pre-requisites  (DH,  2006),
including a minimum of 3 years post-registration clinical experience, the  final  year  being  in  the
clinical field in which they will prescribe. With this dual qualification, nurses may prescribe using
either method (independent  or  supplementary  prescribing)  depending  on  their  particular  work
arrangements and requirements. Nurse prescribers in the UK have the  most  extended  prescribing
rights in the world (Ball, 2009) and over 18,000 in total have undertaken the dual qualification for
NIP/NSP.  There is no information available on a national basis as to how many nurse  prescribers
work in inpatient pain services in the UK.
The introduction of nurse prescribing potentially heralded a  major  change  in  the  way  in  which
pain services could operate. A literature review of nurse-led care in the management of  acute  and
chronic pain (Courtenay and Carey,  2008a)  identified  that  nurses  were  involved  in  medicines
management and giving advice on prescribing, but that nurse prescribing  activity  was  an  under-
researched area. Evidence suggests that pain is  a  therapy  area  for  which  nurses  (working  in  a
range of practice areas)  frequently  prescribe,  both  in  the  UK  (Courtenay  and  Gordon,  2009),
Ireland  (Drennan  et  al.,  2009)  and  the  USA  (Fontana,  2008).  Of  the  pain  nurse   specialists
surveyed by Williamson-Swift (2007),  12%  had  undertaken  a  prescribing  qualification.  When
nurses are able to prescribe for patients in pain, numerous benefits for patients, staff  and  services
have been reported (Stenner and Courtenay 2008b, Kaasalainen et al., 2010). Despite this, there is
a lack of information available about the prescribing practice of nurses both in  the  UK  and  USA
(Cipher et al., 2006) This is hampered by poor  access  to  prescribing  data  from  secondary  care
(hospital services) in the UK.  Given the key role that nurses play in acute pain services, this is  an
important gap in  knowledge.   Improving  the  visibility  of  the  nurse  prescribing  workforce  by
gaining information about nurses and their contribution to inpatient pain management  is  vital  for
the purposes of mapping change in service provision and identifying educational or support  needs
required to optimise best practice.
1.1 Aim
The aim of the study was to determine the number of nurse prescribers working  in  inpatient  pain
services (including APS) across the UK, and to develop a profile of these nurses in terms  of  their
experience, role and prescribing practice.
2. Methods
A descriptive questionnaire survey design was chosen.
2.1       Participants
To  identify  nurse  prescribers  (NIP/NSP)  working  in  inpatient  pain  services,  193   healthcare
provider trusts and health  boards  across  the  UK  were  contacted.  This  comprised  all  National
Health Service (NHS) public hospital acute trusts (as of October  2009),  and  included  167  acute
trusts in England, 14 health boards in Scotland, 7 local health boards in  Wales  and  5  health  and
social care trusts in Northern Ireland. Initial contact was made by telephone to  trust  switchboards
to enquire  about  inpatient  pain  services,  followed  by  contact  with  individual  pain  nurses  or
members of the pain team where possible  within  acute  hospitals.  In  cases  where  a  number  of
hospitals were included under a single trust or  health  board,  contact  was  made  with  individual
hospitals to gain this information. For  Northern  Ireland,  the  number  of  acute  pain  nurses  was
provided by a member of a pain network and nurses contact details were passed to  the  researcher
with permission of these nurses.
A total of 192 inpatient pain services were identified (Table 1), of which 126 (65.6%)  were  acute
pain  services  and  66  (34.3%)  were  integrated  pain  services.  No  inpatient  pain  service   was
identified in 5 trusts and no answer was obtained from 2 trusts. The trusts where no inpatient  pain
service was identified included a women’s hospital, an eye hospital  and  trusts  in  rural  areas.  A
total of 164 qualified nurse prescribers  were  identified  who  worked  in  inpatient  pain  services.
Email addresses of 161 nurse prescribers willing to be invited  to  participate  in  the  survey  were
obtained. We were unable to contact the three remaining nurses during the study period.
2.2       Questionnaire
A 27 item questionnaire was developed specifically for this project (details of which are  available
on request from the  corresponding  author).  In  order  to  allow  comparative  data,  questions  on
professional  background  and  prescribing  practice  replicated,  where  possible,   those   used   in
previous research on nurse prescribing (Courtenay and Carey 2006, Courtenay and  Carey  2008b,
Stenner and Courtenay, 2007) and questions about pain nurse role were based on research in acute
pain services (Clinical Standards Advisory Group, 2000).  A  pilot  was  conducted  with  10  pain
nurse  prescribers  prior  to  dissemination  and   minor   amendments   made.   The   questionnaire
comprised mostly of fixed-choice questions with  some  open-ended  questions  set  out  over  four
sections.  Section  1  covered  demographic  information  (age,  working  hours,  highest  level   of
qualification), type of pain service provided and  numbers  of  nurse  prescribers  working  in  pain
teams. Section 2 asked about prescribing practice (number of years qualified,  prior  experience  in
prescribing, level of specialist training, method of prescribing used,  whether  they  prescribed  for
inpatients or outpatients, and frequency of prescribing). Section 3 asked about types of medication
prescribed for inpatient in pain, the envisaged impact of lifting of controlled  drug  legislation  and
if there were any restrictions on prescribing practice. Section 4 covered the pain management  role
(estimated time spent of different activities, who education was provided  for,  use  of  prescribing
knowledge  to  influence  protocol  or  local  formulary  and  types  of  evidence  used   to   inform
practice). Lastly, participants were asked to rate  the  extent  to  which  prescribing  had  enhanced
ability to promote evidence based practice on  a  four  point  scale  ranging  from  ‘none’  to  ‘very
much’, and asked for general comments.
The questionnaire was designed with  an  internet  based  tool  for  creating  web  surveys  (Survey
Monkey).  An  invitation  letter  outlining  the  study  was  sent  to  nurses  along   with   an   email
containing a link to the online survey. The letter assured  nurses  that  their  details  would  remain
anonymous.
Data  collection  took  place  between  October  and  November  2009.  The  study  gained  ethical
approval from the University of Surrey, Guildford, UK.
2.3       Data analysis
Descriptive statistics were carried out on the data using SPSS statistical software. Non  parametric
tests  were  conducted  to  test  for  significant  correlations  (Spearman’s  Rho),   and   differences
between variables (Chi Square and Mann-Whitney). Yates’s continuity correction was applied  on
two-by-two tables subject to Chi Square. Free text comments were subject to content analysis  and
independently reviewed by a second researcher.
3. Results
Of the 161 nurses invited to complete an online survey, 137 responded, giving a  response  rate  of
85%.
1. Nurse profile
Wide variations in job titles and pay were reported (Table 2). The majority (71.5%,  n=98)  of  job
titles included the term ‘nurse specialist’. There is a  national  pay  structure  for  nurses  in  public
hospitals within the UK with newly qualified nurses  being  paid  band  5.  There  is  then  upward
progression through bands 6, 7 and 8 to band 9 for the highest paid executive nurse. Pay  bandings
for respondents were mainly  those  of  senior  nurse  roles  in  the  UK  (NHS  Employers,  2009).
Details of participants prescribing experience and prior training are also shown on Table 2.
2. Pain service provision
Table 3 shows the setting and type  of  pain  services  that  participants  provided.  A  third  (n=48,
35%) worked across acute/chronic and/or integrated pain services and 90% (n= 123) treated  more
than one pain type, the remainder focusing on either acute (n=8), palliative (n=4)  or  chronic  pain
(n=2). The highest number of nurse prescribers in a pain service was 6. Fifty-three percent  (n=73)
had one nurse prescriber, 46% had two or more per team. Plans to  increase  the  number  of  nurse
prescribers were reported by 30 participants, 13 from teams with only one current prescriber.
3.3       Prescribing practice
NIP was used by 89.5% (n=119), NSP by 12% (n = 16)  and  10%  (n=  14)  were  not  using  their
prescribing qualification, mainly due to delays in obtaining  registered  authorisation  to  prescribe
(n=8), or problems in finding time to arrange a CMP for NSP (n=2). The number  of  items  nurses
prescribed per week is presented in Table 4. For NIP, the highest proportion (29%) prescribed  11-
20 items for inpatients in a typical week.  NSP  was  used  less  often  than  NIP  and  fewer  items
prescribed. The mean number of items prescribed via NIP and NSP respectively was 19.5 and 5.3.
The range of medication prescribed is shown in Table 5. Nurses working only in inpatient settings
prescribed significantly more than those also working  in  out-patient  settings  (Mann-Whitney  Z
value -3.102, p=.002).
3.4       Impact of prescribing and restrictions
Participants  were  asked  to  what  extent  becoming  a  prescriber  had  enhanced  their  ability  to
promote evidence based practice. Responses were ‘None’ (5.8%, n=8),  ‘A  little’  (17.5%,  n=24),
‘Quite a bit’ (27.7%, n=38) and  ‘Very  much’  (40.9%,  n=  56).  There  was  a  medium,  positive
correlation between NIP prescribing  rate  and  the  perceived  impact  of  nurse  prescribing  when
investigated using Spearmans Rank Order Correlation  (r=.367, p<.01).
When  asked  what  the  anticipated  effect  would  be  of  lifting  legislative  restrictions  on  nurse
prescribing of controlled drugs, 16.9%  (n=21)  predicted  it  would  make  no  difference  to  their
prescribing practice, 54.8% (n=68) said it would increase the number of  patients  they  prescribed
for, 69.3% (n=86) said it would increase the range of products they prescribed and 80.6% (n=100)
said it would enable them to provide better pain management. Analysis of open  ended  comments
found  that  many  (n=78)  nurses  were  prevented  by   legislation   from   prescribing   analgesics
commonly used in their workplace. Nurses  had  to  find  a  doctor  to  prescribe  these  medicines,
which took time, introduced room for error, caused frustration and confusion  and  raised  concern
about equality of access to pain medication for different patients,  as  illustrated  by  the  following
comment:
‘Changes to legislation will make significant changes to the timely delivery of analgesia in
acute  pain  management.  In  addition  it  will  reduce  potential  confusion  that  can  arise
between what can be prescribed in palliative care and chronic pain. Our inpatient  caseload
is a complex mix and current regulations increase the risk of potential error  in  prescribing
as our nurses can prescribe from a  range  of  opioids  but  not  for  all  patients.  There  are
inequalities and delays that inevitably result in suffering.’
5. Nurse role and influence
Nurses were asked to estimate the amount of time  they  spent  on  seven  different  activities  in  a
typical working week; possible responses were ‘no time’,  less  than  10%,  10-30%,  30-50%,  50-
70% and 70%+. Figure 1 details the percentage of nurses whose response fell  into  each  of  these
categories for the seven  activities.  On  average,  nurses  spent  19.5%  of  their  time  prescribing,
52.5% on hands-on pain management, 25% on staff education, 23% on  patient  education,  12.4%
on organisational activities and  11.7%  on  research  or  audit.  Comments  made  by  respondents
highlighted that these activities  (such  as  prescribing,  pain  management  and  patient  education)
often overlap and occur at  the  same  time  and  therefore  percentages  do  not  add  up  to  100%.
Spearman’s Rank Order Correlation revealed a significant negative correlation (r= -.302,  p  <.01)
between job band and  involvement  in  patient  education,  indicating  that  nurses  on  higher  pay
bands tend to spend less time on patient education. All participants provided training or  education
to other  healthcare  professionals.  This  included,  in  order  of  frequency:  other  nurses  (98.4%,
n=127), junior doctors  or  house  officers  (93%,  n=120),  students  (91%,  n=117),  allied  health
professionals  (82%,  n=106),  pharmacists  (54%,  n=70),  nurse  prescribers  (38%,   n=49),   and
General Practitioners (21%, n=27).
A  large  majority  (81%,  n  =  102)  had  used  their  clinical  knowledge  and  expertise   in   pain
prescribing to develop local guidance or protocols on pain prescribing, 61% (n =77) had  informed
NHS trust drug formulary  or  Drugs  and  Therapeutic  Committees  (local  regulatory  boards  for
pharmacological practice) on pain prescribing issues. 16.7%  (n  =21)  had  not  been  involved  in
either of these activities. Chi-square Tests showed that nurses on band 8  were  significantly  more
likely than those on band 7 or below to be involved in developing pain protocol (X2 (1, n=  130)  =
4.829, p = .028) and influencing formulary for pain medication  (X2 (1, n= 130) =  9.836,  p=.002).
Nurses reported using a range of sources of evidence to inform their  practice  including  (in  order
of  frequency):  the  British  National  Formulary  (BNF),   World   Health   Organisation   (WHO)
analgesic ladder, local pain  guidelines,  drug  conversion  charts,  journals  and  bulletins  and  the
palliative care formulary.
4. Discussion and conclusion
This study is the first to describe the work and professional profile of nurse  prescribers  who  treat
inpatients in pain. By  making  the  work  of  these  nurses  more  visible,  this  study  provides  an
important basis for future research on how these roles can be evaluated, supported and  developed.
It may also inform debate on the nature and shape of advanced practice within nursing.
4.1       Nurse training and experience
The majority of participants were highly qualified and experienced in their  field.  Over  70%  had
more than 5  years  experience  in  their  main  area  of  practice  prior  to  becoming  a  prescriber,
exceeding criteria for acceptance on the qualifying course (DH, 2006). Age range  and  experience
prior to prescribing were  similar  to  those  reported  in  previous  UK  nurse  prescribing  surveys
(Courtenay et al., 2007, Courtenay and Carey, 2008b). Compared to the most recent UK NIP/NSP
survey  (Courtenay  and  Carey  2008b)  (the  sample  for  which  included  general   practice   and
community based nurses as well as nurse specialists in different areas  of  clinical  practice),  more
pain nurses  worked  full-time,  were  on  higher  pay,  had  a  higher  level  of  education  and  had
undertaken specialist training in  their  area  of  practice  prior  to  prescribing.  The  proportion  of
nurses qualified to masters or PhD level (n =78, 56.9%) was double the 23% previously  described
by  Courtenay  and  Carey  (2008b).  Likewise,  only  7%  of  pain  nurses  reported  no   specialist
qualification or training in their area of practice prior to prescribing  compared  to  35%  of  nurses
surveyed by Courtenay and Carey (2008b).  This level of education is more in line with  the  USA
(Buchan and Calman, 2004), Canada  (Forchuk  &  Kohr,  2009)  and  New  Zealand  (Chaston  &
Seccombe, 2009) where post-graduate education is a requirement for the role of nurse practitioner.
 These findings concur with those of Williamson-Swift’s (2007) survey  where  high  qualification
levels  were  reported  for  specialist  pain  nurses,  confirming  that  pain  nurses  are,  in   general,
dedicated specialists who are committed to advancing their knowledge and education.
4.2       Blurred boundaries of service provision
The range of services in which nurses  were  involved  suggests  a  movement  towards  integrated
pain services. This is in line with observations about the  changing  remit  of  acute  pain  services,
which are expanding out from their original focus  on  post-operative  pain  (Powell  et  al.,  2004,
Counsell, 2008). Likewise, findings indicate a broadening of nurses’ scope of  practice  to  include
more than one service and more than one pain category. Few nurses reported focusing on a  single
pain type. This adds to evidence that pain nurse specialists are  increasingly  working  across  pain
categories, blurring distinctions between acute and chronic pain services (Williamson-Swift 2007)
and may  reflect  the  complexity  of  prescribing  for  inpatients  whose  pain  can  originate  from
multiple and migrating sources. It  is  known  that  nurse  prescribers  find  it  both  confusing  and
restricting  to  work  within  legislation  that  dictates  which  controlled  drugs  can  be  prescribed
according to the origin or pain category, particularly when  treating  patients  who  fall  within  the
grey areas between  pain  categories  (Stenner  and  Courtenay,  2007).  Lifting  these  restrictions,
according to participants, will remove inconsistencies and improve nurses’ ability to provide  pain
management on a fair and equal basis to all patients.
4.3       Prescribing practice
Morphine products (which can be prescribed via NIP for acute  pain  after  trauma,  post-operative
pain relief, palliative care and myocardial infarction) were widely prescribed.  This  is  in  keeping
with the main purpose of acute pain services which is to treat patients in the post-operative period.
 Non-opioids (such as paracetamol, NSAIDs, anti-emetics and laxatives)  and  mild  opioids  (such
as codeine and tramadol) were the most  commonly  prescribed  medicines.  These  are  medicines
with no restrictions under the controlled drugs legislation for nurse prescribing. In contrast, strong
opioids such as fentanyl, buprenorphine, and oxycodone, which NIPs may only  prescribe  for  use
in palliative care, were less commonly prescribed.
As  with  previous  surveys,  nurse  independent   prescribing   was   used   more   frequently   than
supplementary prescribing (Courtenay and Carey,  2008b).  Supplementary  prescribing  has  been
described as impractical, mainly because of difficulties implementing clinical  management  plans
(Stenner and Courtenay, 2007). Barriers to the use of joint prescribing agreements with a  medical
prescriber have also been noted in the USA (Kaplan and Brown, 2007) and  Canada  (Kaasalainen
et al., 2010) with regards to nurse prescribing of controlled substances. The fact that  many  of  the
controlled drugs commonly used to treat pain can only be prescribed in the UK by nurses via NSP
adds to the frustration created by delays in changing appropriate legislation. Our findings  indicate
that the range of medications prescribed by pain nurses qualified to do so  will  increase  once  this
legislation is changed.
The average estimated number of items prescribed per typical week by NIP was slightly higher  at
19.5 than the national average of 17.5 reported by Courtenay and Carey (2008b). There were large
variations between prescribing rates of individual nurses,  the  reasons  for  which  require  further
research. No significant relationships or  correlations  were  found  between  prescribing  rate  and
variables such as age, educational level or pay.  The  lower  inpatient  prescribing  rate  for  nurses
who also worked in outpatient or community pain clinics is probably  due  to  their  spending  less
time in inpatient care than  nurses  working  solely  in  inpatient  settings.  It  is  known  that  some
hospital  based  nurses  and  medics   avoid   prescribing   for   out-patients,   preferring   to   make
recommendations to the patient’s family doctor (General Practitioner)  who,  they  believe,  within
the UK healthcare system, is  better  positioned  to  provide  continuing  care,  gain  full  access  to
patient records and bear the cost of prescriptions (Stenner and Courtenay, 2007).
4.4       Nurse role and influence
A review of  nurse-led  care  in  acute  and  chronic  pain  management  identified  that  nurses  are
involved in areas of pain  assessment  and  monitoring,  interdisciplinary  collaboration,  education
and medicines management (Courtenay and Carey, 2008b). Previous research  on  APS  identified
that acute pain nurses spend an estimated 40% of their time on hands-on  pain  management,  35%
on staff training, 10% on patient education, and 11%  on  audit  and  research  (Clinical  Standards
Advisory Group, 2000). In comparison, nurses in  our  survey  spent  slightly  more  time  on  pain
management (52.3% on average) and patient education (23%), and  less  on  staff  training  (25%).
Other than the addition of prescribing, the patterns of activity were  similar,  indicating  that  these
key elements of the pain nurse role remain the same.
Providing education on pain is considered one of the  key  roles  of  the  pain  nurse  (Williamson-
Swift 2007) and nurse involvement in education for  both  patients  and  staff  has  been  shown  to
improve patient care (Courtenay and Carey, 2008). Almost all participants were  involved  in  pain
education and this was provided to a wide range  of  people.  Importantly,  nurses  considered  that
becoming a prescriber had helped in the promotion of evidence-based practice, to which education
contributed.  Formal  and  informal  education  by  pain  nurses  has  previously  been  reported  as
important for both maintaining skills within teams  and  improving  the  consistency  of  evidence-
based prescribing for pain, particularly amongst less experienced or  junior  doctors  (Stenner  and
Courtenay,  2008a).  The  opportunity  for  nurses  to  influence  local  prescribing  policy  through
representation on appropriate committees has also been reported as a means to promote  evidence-
based practice (Stenner and Courtenay, 2008b). In addition to providing education, participants  in
our study spent an average of 12% of their time on organisation-wide activities  and  many  (83%)
were influencing local pain prescribing policy. Those on higher pay bands were more likely  to  be
involved in developing local policy and  guidelines  on  prescribing  for  pain,  which  reflects  the
alignment of knowledge and skills development with pay banding, as set out  in  the  governments
Agenda for Change initiative (DH, 2004). Nurses in the UK  do  not  receive  additional  pay  as  a
direct result of their prescribing role, however, job  advertisements  for  nurse  specialist  or  nurse
practitioner roles increasingly request that  the  applicants  be  qualified  prescribers  or  willing  to
undertake the course. It would be an interesting subject for future  research  to  determine  whether
there are any implications for the career prospects of nurses who prescribe.
4.5       The future
In contrast to the slow uptake of authority to prescribe controlled substances by nurse practitioners
in the USA (Kaplan and Brown, 2007), results indicate that pain management (and the prescribing
of controlled drugs) is an area in which the use of nurse prescribing is increasing in the  UK.  Over
half the participants (56%) had qualified as a prescriber in the past 3  years  (i.e.  since  2006)  and
22% reported that plans were underway within their pain teams for more nurses  to  undertake  the
qualification.
In order for nurses to obtain permission to train as  a  prescriber  there  should  be  a  demonstrable
local need for this service (DH, 2006).  Inadequate  analgesic  prescribing  by  physicians  coupled
with a shortage of staff, have been cited as reasons for suboptimal  pain  management  on  surgical
wards (Schafheutle et al. 2001). It is anticipated that by  prescribing  for  patients  in  pain,  nurses
will bring about improvements to the efficiency and quality of pain service  provision.  According
to the views of nurse prescribers (Stenner and Courtenay 2008b),  patients  will  experience  fewer
delays in receiving pain medicine in  acute  settings,  are  likely  to  receive  a  higher  standard  of
personalised care and more appropriate  pain  medication  when  under  the  care  of  a  pain  nurse
prescriber.  Additional  benefits  reported   by   pain   nurses   include   improvements   to   service
efficiency, safety, cost-effectiveness, nurse  job  satisfaction,  inter-professional  relationships  and
the learning environment (Stenner and  Courtenay,  2008ab).   While  similar  benefits  have  been
identified through interviews with nurses, doctors and patients in relation  to  diabetes  (Courtenay
et al,. 2009, 2010), dermatology (Carey et al., 2010) and mental health (Jones et  al.,  2007),  there
has been little research on the impact of nurse prescribing  on  pain  services.  While  our  findings
confirm that nurses believe prescribing enhances their ability to promote evidence-based  practice,
further  evidence  is  needed  to  back  these  self-reported  outcomes  and  to  explore  the   patient
perspective. As an increasing number of countries around the world  are  developing  non-medical
prescribing (Ball 2009), continued research in this area would inform and guide this expansion.
4.6       Study limitations
The method used to locate the population of pain nurses was comprehensive, however,  there  may
be nurses who were  not  located  and  invited  to  participate.  Given  the  high  response  rate,  we
believe the findings accurately represent this  population.  While  the  target  population  was  pain
nurses who work in NHS inpatient services, there are other non-medical prescribers who prescribe
pain medication for inpatients who were not included, such  as  night  nurse  practitioners.  Further
work is required to determine the profile and practice of non-medical prescribers working in  NHS
out-patients, pain management clinics and dedicated palliative care services.
4.7       Conclusion
This  study  confirms  that  UK  nurses  are  involved  in  prescribing  for   inpatients   in   pain.   It
emphasises the important role played by pain nurses in prescribing medicines,  pain  management,
educating health professionals and  patients,  contributing  to  audit  and  research,  and  informing
organisational policy.  Given the breadth and influence of the pain nurse role, it is  reassuring  that
these nurses were highly qualified and experienced in their field of practice. The impact that  these
nurses have is likely to increase  when  legislation  restricting  prescribing  of  controlled  drugs  is
removed. There is therefore  a  need  to  give  careful  consideration  to  the  development  of  such
legislation in countries where NMP is advancing. Given the international expansion of NMP, it  is
important that its contribution is evaluated in order to  inform  development  and  enable  optimum
support.
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Table 1. Distribution of nurse prescribers attached to inpatient pain services in UK NHS
trusts
|Area            |No of     |No of   |No of      |No     |No of      |No of nurse |
|                |trusts or |inpatien|trusts     |answer |nurses in  |prescribers |
|                |boards    |t pain  |where no   |       |pain teams*|            |
|                |          |services|pain       |       |           |            |
|                |          |        |service    |       |           |            |
|                |          |        |identified |       |           |            |
|London          |29        |32      |1          |0      |92.2       |23          |
|South central   |11        |11      |0          |0      |36.4       |13          |
|South East Coast|13        |13      |0          |0      |35.2       |13          |
|West midlands   |19        |18      |1          |0      |45         |18          |
|East Midlands   |8         |8       |0          |0      |38.1       |16          |
|North East      |8         |8       |0          |0      |21.2       |7           |
|York & Humber   |15        |14      |0          |1      |34.1       |8           |
|East of England |17        |16      |0          |0      |53.4       |12          |
|North west      |29        |25      |1          |2      |61.1       |16          |
|South west      |18        |18      |0          |0      |50.1       |10          |
|Total for       |167       |163     |3          |3      |466.8      |136         |
|England         |          |        |           |       |           |            |
|                |          |        |           |       |           |            |
|Northern Ireland|5         |-       |-          |-      |16         |7           |
|Wales           |7         |7       |0          |0      |40.1       |7           |
|Scotland        |14        |22      |2          |0      |43.7       |14          |
|Total           |193       |192     |5          |2      |566.6      |164         |
*Numbers represent Whole Time Equivalent (WTE) to account for nurses working part time.
Table 2. Participant profile, experience and training history (n = 137 unless otherwise stated)
Job title                                                            n = number of responses                  % of sample
Clinical/pain nurse specialist                                98                                71.5
Pain nurse/sister                                                    19                                13.9
Lead nurse/team manager                                     10                                7.3
Nurse consultant                                                    6                                  4.4
Nurse practitioner                                                  4                                  2.9
Band
6 or below                                                             17                                12.4%
7                                                                            80                                58.4
8                                                                            40                                29.2
Part time/full time
Full time (>30 hours per week)                             101                              73.7
21-30 hours per week                                            33                                24
<20 hours per week                                               3                                  2.2
Age range
<35 years                                                               6                                  4.4
36-45                                                                     61                                44.5
46-55                                                                     56                                40.9
56 or over                                                              14                                10.2
Highest Academic Qualification (n=136)
Certificate or diploma                                           16                                11.7
Degree                                                                   42                                30.6
Master’s degree                                                     75                                54.7
PhD                                                                       3                                  2.2
Years qualified as a prescriber (n = 130)        
Under 1 year                                                          11                                8
1-3 years                                                                66                                48.2
3-5 years                                                                37                                27
More than 5 years                                                  16                                11.7
Experience in main area of practice
prior to undertaking prescribing training (n = 132)
Under 1 year                                                          0                                  0
1-2 years                                                                6                                  4.4
2-5 years                                                                29                                21.2
More than 5 years                                                  97                                70.8
Prior specialist training in pain (n = 137, multiple answers)
Accredited study days                                           53                                38.7
Masters module or higher                                     74                                54
Degree level module                                             45                                32.8
Diploma level course                                            27                                19.7
Other course                                                          12                                8.7
None                                                                      9                                  6.6
Specialist training post qualifying (n = 137, multiple answers)
Accredited study days                                           54                                39.4
Masters module or higher                                     24                                17.5
Degree level module                                             7                                  5.1
Diploma level course                                            3                                  2.2
Other course                                                          19                                13.8
None                                                                      48                                35
Table 3            Participant involvement in pain service provision (n = 137)
|Pain service setting                    |no      |%       |
|Hospital inpatient only                 |81      |59.1    |
|Hospital in and out-patient             |48      |35      |
|Hospital in/out patient plus community  |8       |5.8     |
|clinic                                  |        |        |
|                                        |        |        |
|Type of pain service                    |        |        |
|Acute Pain Service                      |109     |79.6    |
|Integrated Pain Service                 |44      |32.1    |
|Chronic Pain Service                    |44      |32.1    |
|                                        |        |        |
|Category of pain treated                |        |        |
|Acute pain                              |128     |93.4    |
|Chronic pain                            |88      |64.2    |
|Palliative                              |44      |32.1    |
|Crossover pain, e.g. acute on-chronic   |120     |87.6    |
|Other (substance misuse, paediatrics,   |4       |2.9     |
|sedation weaning and procedural pain).  |        |        |
n.b. figures can be over 100% due to multiple options
Table  4              Number   of   items   prescribed   by   nurses   through   Nurse
Independent Prescribing (NIP) and Nurse  Supplementary  Prescribing  (NSP)
in a typical week.
|               |NIP                         |NSP                         |
|No items       |Frequency  |%      |Valid % |Frequency  |%      |Valid % |
|Less than 1    |2          |1.5    |1.7     |6          |4.4    |37.5    |
|item a week    |           |       |        |           |       |        |
|1-5 items      |17         |12.4   |14.3    |6          |4.4    |37.5    |
|6-10 items     |23         |16.8   |19.3    |3          |2.2    |18.7    |
|11-20 items    |34         |24.8   |28.6    |1          |0.7    |6.25    |
|21-30 items    |22         |16     |18.5    |0          |0      |0       |
|31-40 items    |6          |4.4    |5       |0          |0      |0       |
|41-50 items    |7          |5.1    |5.9     |0          |0      |0       |
|50 + items     |8          |5.8    |6.7     |0          |0      |0       |
|Total          |119        |       |        |16         |       |        |
|Missing        |4          |2.9    |        |4          |2.9    |        |
|Not prescribing|14         |10.2   |        |117        |85     |        |
|Total          |137        |100    |        |137        |100    |        |
Table 5             Medications prescribed by nurses for inpatients in pain (n=137)
|                        |No prescribing|% prescribing   |
|Opioids                 |              |                |
|Codeine products        |109           |79.6            |
|Tramadol                |104           |75.9            |
|Morphine sulphate       |103           |75.2            |
|Morphine sulphate       |95            |69.3            |
|injection               |              |                |
|Modified release        |84            |61.3            |
|morphine products       |              |                |
|Buprenorphine           |41            |29.9            |
|Fentanyl                |40            |29.2            |
|Oxycodone               |34            |24.8            |
|Diamorphine             |30            |21.9            |
|Pethidine               |18            |13.1            |
|Methadone               |9             |6.6             |
|Hydromorphone           |7             |5.1             |
|                        |              |                |
|Non Opioids             |              |                |
|NSAIDs                  |112           |81.7            |
|Anti-emetics            |110           |80.3            |
|Laxatives               |108           |78.8            |
|Compound preparations   |91            |66.4            |
|Anti-convulsants        |90            |65.7            |
|Anti-depressants        |81            |59.1            |

